Lantheus Holdings (LNTH) announced the successful completion of its previously disclosed acquisition of Life Molecular Imaging, a subsidiary of Life Healthcare Group Holdings. As part of the acquisition, Ludger Dinkelborg, PhD, formerly CEO and Managing Director of Life Molecular Imaging (LTGHY), has been appointed Head of Research and Development at Lantheus effective August 1, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LNTH: